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S U M M A R Y
Objectives: To identify the mechanisms responsible for respiratory infections by Acinetobacter baumannii
in intubated patients and risk factors for digestive colonization and infection by A. baumannii.
Methods: We conducted a prospective study in an intensive care unit (ICU) between May 2005 and
November 2006, including 175 consecutive patients at the beginning of invasive ventilation (day 1). We
performed pharyngeal and rectal swabs on days 1, 4, 7, 10, 13, and 16. Respiratory samples were taken on
days 1 and 7, or on suspicion of ventilator-associated pneumonia (VAP).
Results: We detected 62 patients with A. baumannii digestive colonization and 20 cases of A. baumannii
lower respiratory infection (14 VAP and six purulent tracheobronchitis (PTB)). Digestive colonization by
A. baumannii was an independent risk factor for lower respiratory tract infections with that
microorganism (p < 0.0001; relative risk 8.71, 95% conﬁdence interval 2.73–27.77). Respiratory and
rectal A. baumannii isolates from the same patients were compared by enterobacterial repetitive
intergenic consensus (ERIC)-PCR; in 9/11 cases (eight VAP and one PTB) results suggested events of
exogenous pneumonia with previous colonization, whereas the remaining two cases (two PTB) were
suggestive of exogenous infection without previous colonization.
Conclusions: In our unit the pathogenesis of VAP by A. baumannii is mixed, most cases corresponding to
exogenous pneumonia with previous colonization.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Intensive care unit (ICU)-acquired infections are an independent
risk factor for hospital mortality even after adjustment for severity
scores and age.1 Acinetobacter baumannii infections have become
increasingly common among critically ill patients in ICUs world-
wide, causing mainly ventilator-associated pneumonia (VAP).2–4
In some hospitals, epidemic infections become endemic, yet the
clinical and microbiological epidemiology of these infections
remains unclear.5* Corresponding author. Tel.: +598 2487 6981.
E-mail addresses: jcmedina@fmed.edu.uy, jcmedina1@gmail.com
(J.C. Medina-Presentado).
1 M.P.J.C and S.V contributed equally to the experimental work and to the
elaboration of this report.
1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2012.12.025Although A. baumannii can be detected in the airway without
previous colonization,6 colonization of the digestive tract often
precedes VAP. The importance of this event and the subsequent
entry of oropharyngeal content into the trachea in the pathogene-
sis of nosocomial pneumonia have already been suggested.7
Additionally this previous colonization is the basis for strategies
aimed at preventing infections, such as selective decontamination
of the digestive tract (SDD).8
The goals of this work were to identify the proportion of
respiratory infections by A. baumannii preceded by previous
colonization in intubated patients and to investigate the risk
factors for A. baumannii digestive colonization and infection.
2. Methods
We conducted a prospective cohort study at the Hospital de
Clı´nicas, a university referral hospital with a 12-bed medical–
surgical ICU.ses. Published by Elsevier Ltd. All rights reserved.
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All patients admitted from May 1, 2005 to November 31, 2006
with a predicted need for invasive mechanical ventilation of more
than 48 h were included in a successive manner. HIV-positive
patients and solid organ transplant recipients were excluded from
the study.
2.2. Study design
All patients included in this study were followed until death or
discharge from the ICU. The following parameters were recorded:
sex, age, admission diagnosis, severity of underlying disease,9
severity of illness (according to the Acute Physiology and Chronic
Health Evaluation (APACHE) II score) at 24 h after admission and at
the moment of VAP diagnosis, co-morbidities, stress ulcer therapy,
need for reintubation, airway aspiration, previous surgery, cranial
trauma, reasons for the need to mechanically ventilate,10 duration
of mechanical ventilation, and use of systemic antibiotics for more
than 48 h during the previous 15 days and during ICU stay.
2.3. Microbiological processing
In the context of an ongoing program aimed at the surveillance
of dissemination of multiresistant Gram-negative rods within this
ICU, throat and rectal swabs were collected by specialized
personnel upon patient admission to the unit and on days 4, 7,
10, 13, and 16, or until death or discharge.
In addition, a sample was taken from the inspiratory limb of the
ventilator on day 1. Tracheal aspirates were taken on days 1 and 7,
or when VAP was suspected. Bronchoalveolar lavage (BAL) was
performed when VAP was suspected.
Surveillance samples were plated on sheep blood agar and
MacConkey agar with and without 1 mg/l of ceftazidime.
Acinetobacter isolates were identiﬁed as A. calcoaceticus–bauman-
nii complex using standard microbiological methods; identiﬁca-
tion of A. baumannii was further conﬁrmed by PCR for blaOXA-51,
which according to Woodford et al.11 is species-speciﬁc.12
Colonization on admission was considered when A. baumannii
was isolated from any of the admission samples. Colonization was
considered ICU-acquired only when there was no colonization on
admission but A. baumannii was detected in at least one sample
obtained from day 4 onwards.
Deﬁnitions: A conﬁrmative diagnosis of VAP was established if
the following criteria were present: (1) new and persistent
inﬁltrate on chest X-ray; (2) two or more of the following criteria:
rectal temperature 38.5 8C or 36 8C, leukocytosis 12  109/l or
4  109/l, purulent respiratory secretions; and (3) one or more of
the following: (a) isolation of a potential pathogen in BAL ﬂuid with
a bacterial count of at least 10 000 cfu/ml; (b) clinical pulmonary
infection score (CPIS) >6 plus positive semiquantitative tracheal
aspirates;13,14 (c) recovery of identical potential pathogens from
blood cultures and respiratory secretions, in the absence of other
sources of infection; (d) isolation of a potential pathogen from
pleural ﬂuid without previous pleural instrumentation.
Cases of purulent tracheobronchitis (PTB) were diagnosed
following the US Centers for Disease Control and Prevention
deﬁnition.15
In accordance with Hu et al.,16 lower respiratory tract infections
(VAP or PTB) were considered: (1) endogenous when caused by A.
baumannii strains clonally unrelated to A. baumannii isolates
colonizing or infecting other patients; and (2) exogenous when
caused by strains already isolated from other patients, either from
clinical samples or from surveillance cultures (rectal or pharyngeal
swabs). We also registered if patients showed digestive coloniza-
tion with the same strain. In this sense, lower respiratory tractinfections were classiﬁed as endogenous with or without previous
colonization, or exogenous with or without previous colonization.
The presence of A. baumannii isolates in tracheal aspirates in the
absence of VAP or PTB was considered as respiratory colonization.
Acute respiratory distress syndrome, severe sepsis, and septic
shock were diagnosed using standard published criteria.17
2.4. Genotyping
A. baumannii isolates obtained from respiratory and digestive
samples belonging to the same patient were compared by
enterobacterial repetitive intergenic consensus (ERIC)-PCR, in
accordance with Silbert et al.18
2.5. Statistical analysis
Numeric variables were expressed with their standard devia-
tion. We performed Chi-square or Fisher’s exact test accordingly. A
p-value of <0.05 was considered signiﬁcant. Relative risks (RR) and
95% conﬁdence intervals (CI 95%) were calculated using standard
methods. In order to identify independent input variables favoring
the presence of A. baumannii in the respiratory tract, as well as the
digestive system, we performed a multivariate analysis using a
logistic regression model (Enter method) with the aid of SPSS 12.0
software (SPSS Inc., Chicago, IL, USA).
2.6. Ethics
The study did not intervene in the treatment (clinical or
paraclinical) of the patients. Data were handled and results are
presented without disclosing the identity of the patients.
3. Results
3.1. Patients and demographic data
One hundred seventy-ﬁve patients (101 men and 74 women)
were enrolled. The mean age ( standard deviation) of these
patients was 49.7  17.6 years. The median APACHE II score at
admission was 22 (interquartile range 20–26). Demographic and
clinical data of the included patients are shown in Table 1.
3.2. Digestive tract colonization
During the study period, 1306 surveillance samples were taken.
Colonization by A. baumannii was found in 62 patients (35.4%). Twelve
(20%) were already colonized at ICU admission: four were communi-
ty-acquired, whereas eight were acquired on other hospital wards.
The remaining 50 patients (80%) became colonized during their ICU
stay, 23 of whom were colonized from day 4, 20 from day 7, three from
day 10, three from day 13, and one from day 16 (Figure 1). None of the
patients colonized upon admission developed lower respiratory tract
infections. No A. baumannii isolates were recovered from samples of
tracheal aspirates or inspiratory limbs taken on day 1.
3.3. Respiratory infections
A. baumannii isolates were recovered from respiratory samples
(tracheal aspirate or BAL) in 37 patients: 20 from lower respiratory
tract infections (14 VAP and six PTB) and 17 from cases of
respiratory colonization. Table 2 shows the colonization/infection
pattern of those patients with respiratory infection.
Molecular biology tools could be applied to strains obtained
from 11 out of 20 patients with lower respiratory tract infection.
We detected nine cases of respiratory infections with previous
colonization by strains that were either infecting or colonizing
Table 1
Demographic and clinical data of included patients
Variable N = 175
Male gender, n (%) 101 (57.7%)
Age, years, mean (SD) 49.7  17.6
APACHE II score, median (interquartile range) 22 (20–26)
McCabe and Jackson criteria
Rapidly fatal disease, n (%) 1 (0.6%)
Ultimately fatal disease, n (%) 18 (10.3%)
Non-fatal disease, n (%) 156 (89.1%)
Pre-existing comorbidities:
Chronic alcoholism, n (%) 24 (13.7%)
Immunosuppression, n (%) 9 (5.1%)
Hospitalized 3 months before, n (%) 17 (9.7%)
Cardiovascular disease, n (%) 10 (5.7%)
Diabetes, n (%) 14 (8%)
Liver disease, n (%) 4 (2.3%)
Diagnosis at admission:
Non-traumatic ABI, n (%) 31 (17.7%)
Severe CAP, n (%) 11 (6%)
COPD exacerbation, n (%) 4 (2.3%)
Severe trauma, n (%) 43 (24.5%)
Severe sepsis, n (%) 35 (20%)
Cardiovascular disease, n (%) 5 (2.9%)
Cardiac arrest, n (%) 4 (2.3%)
Thoraco-abdominal surgery, n (%) 28 (16%)
Miscellaneous, n (%) 14 (8%)
Previous antibiotic treatment, n (%) 145 (82.9%)
VAP Acinetobacter baumannii, n (%) 14 (8%)
Mechanical ventilation, mean (SD) 12.2  14.8 days
Crude ICU mortality, n (%) 62 (35.4%)
Length of ICU stay, mean (SD) 14.8  15.6 days
APACHE II, Acute Physiology and Chronic Health Evaluation II; ABI, acute brain
injury; CAP, community-acquired pneumonia; COPD, chronic obstructive pulmo-
nary disease; ICU, intensive care unit; SD, standard deviation; VAP, ventilator-
associated pneumonia.
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nia with previous colonization (see Table 2 and Figure 2). The other
two patients were assessed as cases of exogenous infection
without previous colonization (patients 87 and 102, see Table 2
and Figure 2). In both patients the strains colonizing their digestive
tracts were genetically unrelated to the infecting strains.
Regarding the remaining nine patients, we detected previous
colonization in four cases, whereas the other ﬁve corresponded to
events of infection without previous colonization.Figure 1. Distribution of digestive colonization by Acinetobacter baumannii.As shown in Table 2 and Figure 2, we found four different A.
baumannii clones. Clone 1 was present in patients 9, 11, 87 (rectal
sample only), and 110. The ﬁrst two patients were in the unit at the
same time, but patients 87 and 110 were admitted at 8 and 9
months, respectively, after patient 11 was discharged.
Clone 2 was present in patients 33 and 102 (pharyngeal sample
only). Clone 3 was present in four patients: patients 39, 71, 81, and
97. Clone 4 was found in three patients: tracheal aspirates from
patients 87 and 102 and digestive and respiratory samples from
patient 105.
3.4. Risk factors
The association between the presence of A. baumannii in the
digestive tract and the variables under study are shown in Table 3.
Logistic regression analysis pointed to the prior use of oxyimino-
cephalosporins (p = 0.014; RR 2.35, 95% CI 1.18–4.68) and diabetes
(p = 0.036; RR 3.78, 95% CI 1.09–13.08) as the only independent
risk factors for digestive colonization with A. baumannii.
Table 4 indicates the link between respiratory infections by A.
baumannii and the variables under study. In this case, logistic
regression showed digestive colonization with A. baumannii as an
independent risk factor for the development of respiratory
infections with A. baumannii (p < 0.0001; RR 8.71, 95% CI 2.73–
27.77).
4. Discussion
There are few studies analyzing the relationship between
digestive colonization and respiratory infections by A. baumannii,
and the existing information is somewhat incomplete.19,20 To the
best of our knowledge this is the ﬁrst prospective study in Latin
America that has included molecular biology tools to investigate
this matter.
Our main ﬁnding was the demonstration of the occurrence, in
an apparent endemic scenario, of mixed pathogenic mechanisms
responsible for respiratory infections by A. baumannii, most of
them being exogenous with previous pharyngeal and/or rectal
colonization.
We were also able to demonstrate the presence of different
clones co-circulating during the study period, not only within the
ICU, but also among the patients. Regardless of such diversity, all
cases were dubbed as exogenous respiratory infections, most of
them with previous colonization, since the four A. baumannii
clones were detected for prolonged periods of time (e.g., clone 1
was recovered again a year after it was ﬁrst detected). In this sense,
even the ﬁrst isolate of each clone (supposedly index cases) could
have been circulating within this ICU prior to the beginning of our
work.
Our ﬁndings indicate that within our unit A. baumannii displays
a polyclonal endemic behavior, in which those patients developing
infectious processes by this microorganism were previously
colonized with it (14/20). On the other hand a signiﬁcant
proportion of patients (6/20) showed no evidence of previous
colonization. This situation could have at least two probable
explanations: (1) rectal and/or pharyngeal swabs could have a low
sensitivity for the detection of colonization events with a small
bacterial count, which has already been demonstrated for A.
baumannii;21 or (2) direct inoculation of the microorganism into
the respiratory tract, as has been documented for, e.g., K.
pneumoniae.22
Irrespective of this, the digestive tract of patients seems to be a
likely reservoir of strains responsible for infectious processes, as
demonstrated by infections involving clone 1 (Table 2). Unfortu-
nately, we were unable to analyze all the colonizing strains during
the study period in order to thoroughly back up this hypothesis.
Table 2
Pattern of colonization/infection in 20 patients infected by Acinetobacter baumannii
Patient
number
Date of
admission
Date of
discharge
Colonization
at admission
ICU-acquired
colonization
(clone)a
Day of
ICU-acquired
colonization
Type of
infection
(clone)b
Day of acquired
infection
Molecular
relatedness
Mechanism
involvedc
9 15/05/05 2/06/05 No Yes
(Clone 1)
7 VAP
(Clone 1)
8 Yes Exogenous
W/colonization
11 24/05/05 26/08/05 No Yes
(Clone 1)
4 VAP
(Clone 1)
8 Yes Exogenous
W/colonization
33 24/09/05 06/11/05 No Yes
(Clone 2)
16 PTB
(Clone 2)
19 Yes Exogenous
W/colonization
39 30/09/05 09/11/05 No Yes
(Clone 3)
10 VAP
(Clone 3)
14 Yes Exogenous
W/colonization
46 04/11/05 21/11/05 No Yes 7 PTB 15 - Pres. exogenous
W/colonization
54 28/11/05 07/12/05 No No - VAP 9 - Pres. exogenous
WO/colonization
55 26/11/05 12/12/05 No No - PTB 7 - Pres. exogenous
WO/colonization
71 06/01/06 23/01/06 No Yes
(Clone 3)
4 VAP
(Clone 3)
5 Yes Exogenous
W/colonization
73 16/01/06 26/01/06 No No - VAP 4 - Pres. exogenous
WO/colonization
81 30/03/06 07/07/06 No Yes
(Clone 3)
4 VAP
(Clone 3)
7 Yes Exogenous
W/colonization
87 11/04/06 24/04/06 No Yes
(Clone 1)
10 PTB
(Clone 4)
9 No Exogenous
WO/colonization
97 04/05/06 22/06/06 No Yes
(Clone 3)
7 VAP
(Clone 3)
15 Yes Exogenous
W/colonization
102 09/05/06 28/05/06 No Yes
(Clone 2)
4 PTB
(Clone 4)
7 No Exogenous
WO/colonization
105 14/05/06 07/06/06 No Yes
(Clone 4)
4 VAP
(Clone 4)
16 Yes Exogenous
W/colonization
110 29/05/06 02/07/06 No Yes
(Clone 1)
4 VAP
(Clone 1)
14 Yes Exogenous
W/colonization
140 16/07/06 14/09/06 No Yes 7 VAP 5 - Pres. exogenous
WO/colonization
148 08/08/06 28/08/06 No Yes 7 VAP 8 - Pres. exogenous
W/colonization
157 20/09/06 31/10/06 No No - VAP 11 - Pres. exogenous
WO/colonization
166 22/09/06 09/10/06 No Yes 4 VAP 12 - Pres. exogenous
W/colonization
172 14/10/06 12/11/06 No Yes 4 PTB 5 - Pres. exogenous
W/colonization
ICU, intensive care unit; PTB, purulent tracheobronchitis; VAP, ventilator-associated pneumonia.
a Colonizing clone.
b Infecting clone.
c With (W), without (WO), presumptively (Pres).
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baumannii in 62 patients (35.4%), a proportion similar to that
previously reported by other authors.19,20 Of these, 88.7% (n = 55)
were detected within the ﬁrst 7 days of admission to the ICU, whichFigure 2. Comparison of Acinetobacter baumannii strains obtained from patients that yiel
performed for strains from 11 cases. 1, ladder; 2, 9.3R; 3, 9TA; 4, 11.2P; 5, 11TA; 6, 110.2R;
97.2R; 16, 97TA; 17, 33.6P; 18, 33TA; 19, 87.4R; 20, 87TA; 21, 105.5P; 22, 105TA; 23, suggests that in our unit A. baumannii colonizes patients faster than
previously reported.5
Logistic regression identiﬁed the previous use of oxyiminoce-
phalosporins as a risk factor for digestive colonization by A.ded this microorganism in digestive and respiratory samples. ERIC-PCR assays were
 7, 110TA; 8, ladder; 9, 39.4P; 10, 39TA; 11, 71.2R; 12, 71BAL; 13, 81.3P; 14, 81TA; 15,
102.2P; 24, 102TA.
Table 3
Relationship between the occurrence of Acinetobacter baumannii in the digestive tract and different variables. Logistic regression analysis
Variables Digestive colonization
n = 62
No digestive colonization
n = 113
Univariate analysis Multivariate analysis
RR (95% CI) p-Value RR (95% CI) p-Value
Neurocritical 29 (46.8%) 41 (36.3%) 1.54 (0.82–2.89) 0.19 1.82 (0.92–3.59) 0.08
Reintubation 9 (14.5%) 7 (6.2%) 2.57 (0.90–7.28) 0.09 2.16 (0.68–6.86) 0.19
Previous use of oxyiminocephalosporinsa 28 (45.2%) 27 (23.9%) 2.62 (1.35–5.08) 0.006 2.35 (1.18–4.68) 0.014
Hemodialysis 4 (6.5%) 1 (0.9%) 7.72 (0.84–70.7) 0.05 4.37 (0.38–50.33) 0.23
Diabetes 9 (14.5%) 5 (4.4%) 3.66 (1.17–11.4) 0.037 3.78 (1.09–13.08) 0.036
RR, relative risk; CI, conﬁdence interval.
a Oxyiminocephalosporins: cefuroxime, ceftriaxone, ceftazidime, cefotaxime.
Table 4
Relationship between respiratory infection by Acinetobacter baumannii and different variables. Univariate analysis and logistic regression
Variables Respiratory infection
n = 20
No respiratory infection
n = 155
Univariate analysis Multivariate analysis
RR (95% CI) p-Value RR (95% CI) p-Value
Occurrence of A. baumannii in digestive tract 16 (80%) 46 (29.7%) 9.47 (3.00–29.89) <0.001 8.71 (2.73–27.77) <0.001
Previous use of oxyiminocephalosporinsa 12 (60%) 43 (27.7%) 3.90 (1.49–10.21) 0.009 3.27 (0.90–11.89) 0.071
Reintubation 5 (25%) 11 (7.1%) 4.36 (1.33–14.24) 0.022 - -
RR, relative risk; CI, conﬁdence interval.
a Oxyiminocephalosporins: cefuroxime, ceftriaxone, ceftazidime, cefotaxime.
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predisposing factors for digestive colonization by this microor-
ganism,23,24 as well as by oxyiminocephalosporin-resistant Enter-
obacteriaceae.25
We could thus formulate the following chain of events: once
admitted to the ICU, those patients treated with oxyiminocepha-
losporins become a risk group for digestive colonization with A.
baumannii, which in turn constitutes a predisposing factor for the
colonization of the lower respiratory tract and further develop-
ment of infections. Our group has already demonstrated that
previous use of ceftriaxone and ciproﬂoxacin are independent risk
factors for the development of A. baumannii VAP,26 and that the
restricted use of both antibiotics helps to decrease the incidence of
that pathogen.27
This theory supports the ﬁnding of other authors concerning the
importance of patients as ‘reservoirs’ for this microorganism.28 In
this sense, several authors have pointed out that clinical infections
are more frequent in patients with A. baumannii digestive
colonization.28,29
In our ICU, respiratory infections by A. baumannii can be abated
only by multimodal strategies that take into consideration both the
pathogenesis and epidemiology of that microorganism.8 Concern-
ing SDD, several studies have demonstrated that selective
decontamination regimes are associated with a decrease in VAP
and mortality among patients in ICUs.30,31 SDD could be
considered as a reasonable additional control measure, in view
of the high rates of fecal carriage observed in A. baumannii
outbreaks.32
In conclusion, in our particular setting, gut colonization
precedes respiratory infections in up to 70% of cases, on account
of different endemic clones of A. baumannii. Further studies are
needed to evaluate the impact of multi-intervention strategies to
control this endemic situation.
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